Homocysteine and Cognitive Impairment

Publisher： Karger

E-ISSN： 1421-9824|26|6|506-512

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.26, Iss.6, 2008-11, pp. : 506-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Homocysteine and Risk of Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 1, 2008-12 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 1, 1998-12 ,pp. : 12-20

Karger

Access to resources Recommend Favorite

Homocysteine as a Risk Factor for Cognitive Impairment in Stroke Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 3, 2003-02 ,pp. : 155-162

Karger

Access to resources Recommend Favorite

Homocysteine, Apolipoproteine E and Methylenetetrahydrofolate Reductase in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 2, 2003-06 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Homocysteine and C-Reactive Protein Are Not Markers of Cognitive Impairment in Patients with Major Cardiovascular Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 4, 2008-03 ,pp. : 309-316

Karger

Access to resources Recommend Favorite